Researchers discovered that certain antibodies employ unusual tactics to block bacterial adhesion, including creating molecular wedges and conformational traps. These mechanisms could lead to the development of immune therapies targeting glycan-binding cell-attachment proteins produced by bacteria causing urinary tract infections.
The dengue virus uses its envelope protein to capture human plasmin, enhancing the permeability of the mosquito midgut. This interaction is crucial for viral infection, and understanding it could lead to innovative approaches to tackle vector-borne viruses.
Researchers developed a nanoparticle-based vaccine that generates antibodies targeting conserved regions of sarbecovirus receptor-binding proteins, offering broader protection against multiple strains. The vaccine demonstrated strong antibody responses and protection in animal studies against diverse SARS-CoV-2 and other sarbecoviruses.
Researchers uncover new insights into protein signal transduction, revealing key details about GRB2 and SOS1's role in passing signals. They discovered differences in the domains' dynamics and binding affinities, providing a more detailed mechanism for liquid-liquid phase separation.
Scientists have discovered a long non-coding RNA called CHASERR that regulates the production of the CHD2 gene, which is associated with neurodevelopmental disorders. The study found that patients with a deletion of this RNA had excessive CHD2 protein production, leading to severe intellectual delays and other symptoms.
Researchers at U of T have discovered that C2H2 zinc finger proteins, which primarily bind to DNA, also regulate RNA processing through various mechanisms. These proteins modify mRNA, controlling its length and altering it after transcription.
Researchers at Hokkaido University have developed a comprehensive derivative synthesis method to find new antimicrobial drugs. They identified eight analogs possessing strong MraY inhibitory and antibacterial activity, with one showing promising effectiveness in mouse infection models.
A region in alpha-synuclein protein aggregates has been identified as a potential therapeutic target to prevent conversion into toxic amyloid fibrils, which accumulate in the brains of people suffering from Parkinson's disease. The discovery opens the door to developing new therapeutic strategies for inactivating these toxic forms.
A research team has made a significant breakthrough in understanding the GPR156 receptor protein's role in maintaining auditory function. The study reveals that GPR156 exhibits sustained activity even without external stimuli, highlighting its potential as a target for treating congenital hearing impairments.
Researchers at University at Buffalo propose a new approach to developing cancer drugs by determining the optimal placement of molecular linkers earlier in the process, reducing trial and error and increasing potency, according to a study published in Communications Chemistry.
Delta opioid receptors play a crucial role in anxiety development, and research reveals its therapeutic effects in animal models. KNT-127, a DOP agonist, reduces anxiety-like behavior by suppressing glutamatergic transmission, offering new potential for treating anxiety disorders.
Researchers have found a way to control MYC's hyperactivity using a peptide compound with sub-micro-molar affinity. This breakthrough offers hope for more effective treatments for cancer patients.
Researchers investigate centro-cingulate network changes and cholinergic innervation deficits in Parkinson disease and normal aging. Studies reveal significant correlations between centro-cingulate changes and cognitive impairments, motor symptoms, and age.
A new technology has identified a genetic abnormality causing xeroderma pigmentosum (XP)-F, a skin disorder. The technique effectively reversed many cellular phenotypes associated with XP and may be effective for genetic treatments of other diseases.
HSE biologists explain how coronavirus evolves from Wuhan variant to Omicron, highlighting the crucial role of microRNA molecules in the process. The study found that substitutions in the viral genome disrupted microRNA binding regions, leading to the emergence of more contagious and resilient strains.
Researchers isolated antibodies from a vaccinated SARS patient that can stop nearly all related coronaviruses tested. The most powerful antibody, E7, neutralizes SARS-CoV and Omicron variants, showing a unique mechanism of binding to the virus's spike protein.
The study identifies 1,074 semi-extractable RNAs potentially involved in phase-separated membraneless organelles. These RNAs are enriched in repressed heterochromatin regions and act as hubs for RNA-RNA interactions.
Researchers have identified two effective antibodies that neutralize all known strains of COVID-19, including Delta and Omicron variants. These breakthrough antibodies could eliminate the need for repeated booster vaccinations and strengthen immune systems, especially in at-risk populations.
A novel chemical tool, ADdis-Cys, has been developed to elucidate protein interaction networks in cells. It enables the simultaneous identification of a protein's interacting partners and pinpointing of their binding regions.
Researchers found a molecular switch mechanism that regulates biological clocks, explaining how mutations can shorten clock timing. This discovery may enable the development of therapies to alleviate disruptions caused by clock dysregulation.
Researchers at Nagoya University and Tsinghua University have analyzed the crystal structure of LURE bound to its receptor protein PRK6, revealing a unique binding scheme that controls pollen tube growth. The study provides insights into the precise mechanism of direction control in fertilization.
A new study published in Scientific Reports reveals that non-canonical microRNA binding is widespread, targeting both protein-coding genes and non-coding RNAs. This suggests a more complex role for microRNAs in regulating gene abundance levels.
Researchers identified a mutation in the carbohydrate sulfotransferase 3 gene associated with early-onset lumbar disc degeneration. Decreased CHST3 expression was found to predict LDD development, providing new insights into the genetic causes of this condition.
Researchers identified differences in transcription factor binding to DNA that affect gene expression in different people. Variability in these regulatory regions can influence disease susceptibility and gene product levels.